Shaan Dudani

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Emergency Medical

Tyrosine Kinase

Metastatic Renal Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Parneet K Cheema, Marco A J Iafolla, Massey Nematollahi, FeRevelyn Berco, Deepanjali Kaushik, Priscilla Matthews, William R Raskin, Kirstin A Perdrizet, Shaan Dudani, Juhi Husain, Margaret Balcewicz, Philip G Kuruvilla, Stephen M Reingold, Henry J Conter
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre. Current oncology (Toronto, Ont.) 29 (2) (2022)
Brandon S Sheffield, Andrea Beharry, Joanne Diep, Kirstin A Perdrizet, Marco A J Iafolla, William Raskin, Shaan Dudani, Mary Anne Brett, Blerta Starova, Brian Olsen, Parneet K Cheema
Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care. Current oncology (Toronto, Ont.) 29 (3) (2022)
Kevin Shee, Sumanta Kumar Pal, J Connor Wells, Jose Manuel Ruiz-Morales, Kenton Russell, Shaan Dudani, Toni K Choueiri, Daniel Y C Heng, John L Gore, Anobel Y Odisho
Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer. JCO clinical cancer informatics 5 (2021)
Alind Gupta, Paul Arora, Darren R Brenner, Jacqueline Vanderpuye-Orgle, Devon J Boyne, Mark Edmondson-Jones, Elena Parkhomenko, Warren Stevens, Shaan Dudani, Daniel Y C Heng, Samuel Wagner, John Borrill, Elise Wu
Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma. JCO clinical cancer informatics 5 (2021)
Shaan Dudani, Horia Marginean, Patricia A Tang, Jose G Monzon, Soundouss Raissouni, Timothy R Asmis, Rachel A Goodwin, Joanna Gotfrit, Winson Y Cheung, Michael M Vickers
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC cancer 19 (1) (2019)